SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending as community members rally around the project's real-world applications and growing brand presence, emphasizing their active involvement and long-term vision. The community highlights KENDU's expanding ecosystem, including energy drinks, merchandise, and a passionate street team, reinforcing their commitment to building a recognizable global brand. Enthusiasts express strong conviction in KENDU's potential, promoting its unique position as a community-driven brand coin.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending as investors digest recent earnings and a newly authorized share buyback, with community sentiment split between those seeing a buying opportunity at lower prices and others expressing concerns about competition and overall market conditions. Some analysts are maintaining positive outlooks, while community members debate the impact of political ad spending and potential for a short squeeze. Technical analysis suggests the stock is oversold, potentially setting up for a reversal.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

SERV is trending following news of a multi-year partnership with DoorDash to expand autonomous robot delivery services, with community members anticipating a rise to previous highs. Some are speculating on potential acquisitions and increased revenue in 2026 from expanded robot deployments, while others are closely watching short interest and technical indicators for potential squeeze opportunities. Overall, the community is excited about the potential for autonomous delivery to become mainstream.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

RCL is trending amid mixed sentiment, with some investors expressing concern over the stock's recent performance and potential overvaluation.  Despite positive comments regarding the cruise industry's recovery, some community members are anticipating a pullback.  Overall, the stock's trajectory and earnings potential are key points of discussion among investors.

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Carmax Inc

CarMax ($KMX) is trending as investors assess the impact of a CEO change and weak preliminary results, while the community debates whether it's a buying opportunity or a sign of deeper issues. Some believe the stock is undervalued, citing BlackRock's ownership and potential for a price jump with a new CEO, while others point to downgrades and comparisons to Carvana ($CVNA) as reasons for concern amid a challenging used car market.

Asana, Inc. engages in the business of developing a work management platform that helps organizations orchestrate work from daily tasks to cross-functional strategic initiatives. The company was founded by Dustin Moskovitz and Justin Michael Rosenstein on December 16, 2008 and is headquartered in San Francisco, CA.

Asana Inc - Ordinary Shares - Class A

Asana Inc

Asana is trending amid discussions about its latest earnings report and guidance, with some analysts downgrading the stock despite a revenue beat. The community is focused on insider trading activity, particularly CEO Dustin Moskovitz's past and potential future share purchases, and speculating about a possible buyout. Sentiment is mixed, with some investors expressing frustration and others anticipating a potential squeeze.

Digital Realty Trust, Inc. operates as a real estate investment trust, which engages in the provision of data center, colocation and interconnection solutions. It serves the following industries: artificial intelligence (AI), networks, cloud, digital media, mobile, financial services, healthcare, and gaming. The company was founded on March 9, 2004, and is headquartered in Dallas, TX.

Digital Realty Trust Inc

Digital Realty is trending as investors discuss the REIT's position to capitalize on AI-driven demand for data centers, with some highlighting the potential for partnerships like the one with NVIDIA to set future standards. Community members are debating valuation metrics like P/E ratio and dividend payout, while analysts are adjusting price targets based on recent earnings and guidance. Discussions also include infrastructure buildout and strategic moves to address enterprise AI challenges.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster ($OUST) is trending amid analyst upgrades and community optimism, with Cantor Fitzgerald recently adjusting its rating to Overweight.  Investors are actively discussing partnerships with Serve Robotics and May Mobility, as well as potential applications of Ouster's LiDAR technology in self-driving cars and defense.  Community members are also speculating on upcoming earnings and the potential for Ouster to solidify its position in the autonomous vehicle market.

Nova Minerals Ltd. engages in the exploration and development of mineral properties. Its projects include Estelle Gold, RPM, Korbel, Train, Stoney and Studies projects. The company was founded in January 1987 and is headquartered in Melbourne, Australia.

Nova Minerals Limited - ADR

Nova Minerals is trending as the market anticipates potential benefits from upcoming high-level critical minerals discussions between the U.S. and Australia, especially given the recent Department of Defense grant awarded to the company. Community members are focused on the company's gold and antimony prospects, with some speculating about a possible government stake and significant upside potential.

SolarEdge Technologies, Inc. engages in the development of energy technology, which provides inverter solutions. The firm operates through the following segments: Solar and All Other. The Solar segment includes the design, development, manufacturing, and sales of an inverter solution designed to maximize power generation. The All Other segment includes the design, development, manufacturing and sales of UPS products, energy storage products, e-Mobility products, and automated machines. Its products and services include photovoltaic inverters, power optimizers, photovoltaic monitoring, software tools, and electric vehicle chargers. The company was founded by Guy Sella, Lior Handelsman, Yoav Galin, Meir Adest, and Amir Fishelov on August 7, 2006 and is headquartered in Herzliya, Israel.

Solaredge Technologies Inc

Solaredge Technologies is trending as the stock approaches its 52-week high, with analysts adjusting price targets amid discussions of potential resistance levels. Bullish sentiment is fueled by the company's strategic positioning in the energy sector, while some traders are closely watching short interest and potential pullbacks. Community members are actively debating the stock's valuation and future prospects, considering both bullish and bearish scenarios.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kura Oncology FY2025 EPS Forecast Cut by Cantor Fitzgerald

Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Research analysts at Cantor Fitzgerald dropped their FY2025 EPS estimates for Kura Oncology in a research note issued to investors on Wednesday...

Kura Oncology FY2025 EPS Forecast Reduced by Leerink Partnrs

Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Analysts at Leerink Partnrs decreased their FY2025 earnings per share estimates for Kura Oncology in a research report issued on Tuesday, November...

FY2025 Earnings Forecast for Kura Oncology Issued By Wedbush

Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Investment analysts at Wedbush boosted their FY2025 earnings estimates for shares of Kura Oncology in a report issued on Tuesday, November 4th...

Brokers Offer Predictions for Kura Oncology FY2025 Earnings

Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities researchers at Brookline Capital Management cut their FY2025 earnings per share estimates for shares of Kura Oncology in a report released...

Kura Oncology FY2025 EPS Estimate Boosted by HC Wainwright

Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - HC Wainwright lifted their FY2025 earnings estimates for Kura Oncology in a note issued to investors on Tuesday, November 4th. HC Wainwright analyst...

Brokers Offer Predictions for Kura Oncology FY2027 Earnings

Kura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities researchers at Brookline Capital Management reduced their FY2027 earnings per share (EPS) estimates for shares of Kura Oncology in a...

Kura Oncology (KURA) Reports Q3 Loss, Lags Revenue Estimates

Kura Oncology (KURA) delivered earnings and revenue surprises of -49.12% and -75.72%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

<ul class="summary-bullets"><li>The payment was in connection with the dosing of the first patient in a late-stage registrational trial of Ziftomenib.</li><li>Kura Oncology and Kyowa Kirin had entered into a deal in November 2024 to jointly develop and commercialize Ziftomenib. &nbsp;</li></ul>Kura Oncology (KURA) said on Friday that it received a $30 million milestone payment under its collaboration agreement with Japan-based Kyowa Kirin, inked late last year.The <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/24/3172720/35186/en/Kura-Oncology-Receives-30-Million-Development-Milestone-Payment-in-Ziftomenib-AML-Program-with-Kyowa-Kirin.html">payment</a> was in connection with the dosing of the first patient in a late-stage registrational program of Ziftomenib evaluating the drug in combination with both intensive and non-intensive chemotherapy regimens in patients with newly diagnosed acute myeloid leukemia with certain conditions. The companies announced the launch of the said trial on September 29.The program includes two late-stage trials intended to support potential U.S. accelerated approval and full approval. The trial is expected to enroll patients at up to 200 sites worldwide.According to Kura, the late-stage program is the only menin inhibitor program actively pursuing registrational trials across both intensive and non-intensive chemotherapy settings.<h2 class="st-heading-2">Terms Of The Deal</h2>Kura Oncology and Kyowa Kirin had entered into a deal in November 2024 to jointly develop and commercialize Ziftomenib. Under the agreement, Kura is eligible to receive up to $1.2 billion in total milestone payments, including near-term milestone payments. &nbsp;As per the terms of the agreement, Kura will lead development, regulatory, and commercial strategy in the U.S. while Kyowa leads it outside the U.S.<a href="https://stocktwits.com/symbol/KURA">KURA shares</a> traded 6% higher in the pre-market session at the time of writing. On Stocktwits, retail sentiment around KURA stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume stayed at ‘high’ levels.KURA stock is up by over 4% this year but down by about 49% over the past 12 months.Read also:<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/jp-morgan-to-let-clients-use-bitcoin-ethereum-as-loan-collateral-by-year-end/cLGJVtKR3sH"> JPMorgan To Let Clients Use Bitcoin, Ethereum As Loan Collateral By Year-End: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

KURA Stock Rises Pre-Market After Receiving Milestone Payment Related To Cancer Drug Development Agreement

The payment was in connection with the dosing of the first patient in a late-stage registrational trial of Ziftomenib.

Equity

Kura Oncology (KURA) Reports Q2 Loss, Lags Revenue Estimates

Kura Oncology (KURA) delivered earnings and revenue surprises of -600.00% and -89.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Is the Options Market Predicting a Spike in Kura Oncology Stock?

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$9.86
Prev Close	$10.16
Open	$10.02
Dividend Yield	0.00%
50-Day Moving Average	$9.20
Beta	0.99
Avg. Volume	1.91M
PE Ratio	-3.98

52-Week High	$19.73
52-Week Low	$5.41
Market Capitalization	$857.99M
EPS (Annual)	-$2.02
Price to Book	3.54
Revenue Per Employee	$280,640.63
Enterprise Value/EBITDA	N/A

KURA
Kura Oncology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KURA News

KURAKura Oncology Inc